The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

To suit the needs of the human papillomaviruses (HPV) community comprehensively, a
range of commercial HPV tests with different performance characteristics are required. Four …

Cervical cancer remains a significant global health burden, necessitating innovative
approaches for improved diagnostics and personalized treatment strategies. Precision …

Cervical cancer (CC) continues to be a major worldwide health concern, profoundly
impacting the lives of countless females worldwide. In low-and middle-income countries …

As the fourth most diagnosed cancer, cervical cancer (CC) is one of the major causes of
cancer-related mortality affecting females globally, particularly when diagnosed at advanced …

The aim of this study is to identify potential biomarkers for early diagnosis of gynecologic
cancer in order to improve survival. Cervical cancer (CC) and endometrial cancer (EC) are …

Background To investigate the value of carcinoembryonic antigen (CEA), cytokeratin 19
fragment (CYFRA21-1), squamous cell carcinoma antigen (SCC-Ag), and gastrin-releasing …

Cancer of the cervix uteri is the fourth most common cancer worldwide with a high mortality
rate. Due to limitations of the existing methods, alternative methods for triage are needed for …

Cervical cancer remains a leading cause of cancer-related deaths in women worldwide, with
limited treatment options for advanced stages and therapy-resistant cases. Despite …

This article provides an informative overview of the current situation and future trends in
cervical cancer prevention. Cervical cancer remains a significant public health concern …